Healthtech funding in October 2022
European Healthtech startup funding raised during October 2022.
In October 2022, 66 European Healthtech companies closed 66 funding rounds and raised €711M in equity funding (excluding debt and grants), down 16.7% versus October 2021. Debt rounds added €15M. Switzerland led by capital raised, and Biopôle Start-up Fund was the most active investor. Data as of 20 Nov 2026.
Equity funding
€711M
-16.7% vs October 2021 · excl. debt & grants · +€15M debt
Funding rounds
66
+1.5% vs October 2021
Companies
66
Top country
Switzerland
Rank among sectors
#3
12.7% of sector funding
Debt financing
€15M
2.1% of total
Top-10 round share
62.6%
of disclosed capital
Rounds ≥ €100M
1
Top countries
by € raisedHealthtech — top countries by capital, October 2022 — interactive chart.
Data table
| Healthtech — top countries by capital, October 2022 | |
|---|---|
| Switzerland | €195M |
| Germany | €166M |
| UK | €88M |
| France | €82M |
| Netherlands | €51M |
| Belgium | €47M |
| Spain | €31M |
| Italy | €25M |
Stage mix
by € raisedHealthtech — stage mix, October 2022 — interactive chart.
Data table
| Healthtech — stage mix, October 2022 | |
|---|---|
| Other | €347M |
| Series A | €256M |
| Series B | €85M |
| Debt | €15M |
| Seed | €15M |
| Pre-Seed | €8.4M |
Top deals
largest disclosed rounds in October 2022| Company | Stage | Date | Amount |
|---|---|---|---|
| Vectivbio | Other | Oct 2022 | €127M |
| Resolve Biosciences | Series B | Oct 2022 | €72M |
| Univercells | Other | Oct 2022 | €44M |
| Nucleome Therapeutics | Series A | Oct 2022 | €38M |
| anokion | Other | Oct 2022 | €36M |
| Mablink Bioscience | Series A | Oct 2022 | €31M |
| Aqemia | Series A | Oct 2022 | €30M |
| Patronus | Series A | Oct 2022 | €27M |
| Micreos | Other | Oct 2022 | €25M |
| Araris Biotech | Other | Oct 2022 | €24M |
| Sibylla Biotech | Series A | Oct 2022 | €23M |
| Bob W | Series A | Oct 2022 | €21M |
| anvajo | Other | Oct 2022 | €18M |
| SpinDiag | Debt | Oct 2022 | €15M |
| OpenUp | Series A | Oct 2022 | €15M |
Top investors
most active in October 2022, by deal count- Biopôle Start-up Fund2 deals
- Verve Ventures2 deals
- VI Partners2 deals
- 3B Future Health Fund1 deals
- 3D1 deals
- 4BIO Capital1 deals
- AAL Programme1 deals
- ACF investors1 deals
- Achmea Innovation Fund1 deals
- Adjacent1 deals